Potential role of Chinese medicine nanoparticles to treat coronary artery disease

Rongyuan Yang, Yingming Gu, Jinying Qin,Qingqing Liu,Qing Liu

HELIYON(2023)

引用 0|浏览2
暂无评分
摘要
Coronary artery disease (CAD) is a leading cause of death worldwide, while conventional treatments such as percutaneous coronary intervention (PCI) have limitations. This review aims to explore the potential of nanoparticles loaded with Chinese medicine in the treatment of CAD. We conducted a comprehensive literature search to summarize the characteristics of nanovehicle systems, targeting strategies, and administration methods of various nanoparticles containing Chinese medicine for CAD treatment. Nanoparticle-based drug delivery systems, capable of delivering Chinese medicine, offer several advantages, including high targeting efficiency, prolonged half-life, and low systemic toxicity, making them promising for CAD treatment. Overall, nanoparticles containing Chinese medicine present a promising approach for the treatment of CAD.
更多
查看译文
关键词
Nanoparticle,Coronary artery disease,Chinese medicine,Drug delivery system,Targeting strategy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要